You have entered the IISP: Interactive Information System on Pathogenomics
If you would like to insert information about your research or research group, please click to the following link to download the form. After filling it out, please send back to email@example.com or firstname.lastname@example.org.
Here you will find information about Research groups in the PathoGenoMics fields from the ERA-NET partner countries (Austria, Finland, France, Hungary, Israel, Latvia, Portugal, Slovenia and Spain).
This information is supposed to support cooperation between researchers from different European countries
and thus enhance the development of a European Research Area for PathoGenoMics .
The following information is available and can be searched for:
- researcher names
- Institution of the respective researcher, city and country of his/her institution
- Contact data of the researcher (address, phone, email)
- Research topics and studied microorganisms of the researcher
- Special techniques applied by the researcher
- Potential cooperation topics suggested by the researcher
If you have any comments/questions or if you would like to add some information, please contact email@example.com
|Name:||Prof. Dr. Meyer, Thomas F.|
|Institution:||MPI für Infektionsbiologie|
|In the focus of the Department of Molecular Biology are the host cellular processes induced upon infection with bacterial pathogens. Several pathogen models serve to contribute to our understanding of molecular mechanisms of the infection including principle bacterial virulence mechanisms, receptor-mediated interactions with target cells and pathogen-induced signal transduction cascades. One key interest is the understanding of cellular processes and host cell factors relevant for intracellular pathogen accommodation. Furthermore, we are concerned with the analysis of mechanisms underlying chronic infection and its consequences on inflammation, cell damage and genotoxicity. Finally, using H. pylori as a model we aim to understand pathogen-specific immune response mechanisms and, in order to assess new approaches of protection against H. pylori infection, we currently evaluate novel vaccine candidates in clinical settings. To achieve our scientific goals we employ a spectrum of advanced methodologies enabling pathogen genetics, cell biology and signalling studies, basic and applied immunology, high-resolution microscopy, mutation analyses and RNA interference as well as global approaches in genomics and proteomics; thus, a stimulating research environment is generated.|
|Special methods / technologies:|
|RNAi, molecular genetics, immunology, cell biology, epidemiology, clinical research and protein chemistry|
|Suggestions for potential research cooperations:|